Search Results - "Prince, Peter J."
-
1
Prediction of clinical pharmacokinetics of AMG 181, a human anti‐α4β7 monoclonal antibody for treating inflammatory bowel diseases
Published in Pharmacology research & perspectives (01-02-2015)“…The purpose of this study was to predict a safe starting dose of AMG 181, a human anti‐α4β7 antibody for treating inflammatory bowel diseases, based on…”
Get full text
Journal Article -
2
Clinical pharmacology of AMG 181, a gut‐specific human anti‐α4β7 monoclonal antibody, for treating inflammatory bowel diseases
Published in British journal of clinical pharmacology (01-12-2014)“…Aims AMG 181 pharmacokinetics/pharmacodynamics (PK/PD), safety, tolerability and effects after single subcutaneous (s.c.) or intravenous (i.v.) administration…”
Get full text
Journal Article -
3
Off-Target Platelet Activation in Macaques Unique to a Therapeutic Monoclonal Antibody
Published in Toxicologic pathology (01-08-2012)“…AMG X, a human neutralizing monoclonal antibody (mAb) against a soluble human protein, caused thrombocytopenia, platelet activation, reduced mean arterial…”
Get full text
Journal Article -
4
Measurement of in vivo therapeutic mAb concentrations: comparison of conventional serum/plasma collection and analysis to dried blood spot sampling
Published in Bioanalysis (01-08-2013)“…Development of an alternative sampling method that uses small amounts of whole blood, such as dried blood spots (DBS), would be an advance in the quantitative…”
Get full text
Journal Article -
5
-
6
-
7
Assessment of DBS technology for the detection of therapeutic antibodies
Published in Bioanalysis (01-08-2010)“…Quantitating levels of therapeutic proteins in serum or plasma is critical for determining exposure levels and establishing pharmacokinetic parameters…”
Get more information
Journal Article -
8
-
9
Prediction of clinical pharmacokinetics of AMG 181, a human anti-α 4 β 7 monoclonal antibody for treating inflammatory bowel diseases
Published in Pharmacology research & perspectives (01-02-2015)“…The purpose of this study was to predict a safe starting dose of AMG 181, a human anti-α 4 β 7 antibody for treating inflammatory bowel diseases, based on…”
Get full text
Journal Article -
10